North American Thrombosis Forum Right Heart Symposium 2023
$20.00
North American Thrombosis Forum Right Heart Symposium 2023 Pulmonary vascular disease (PVD), including pre- and post-capillary pulmonary hypertension, are a spectrum of progressive, symptomatic, and ultimately fatal disorders for which significant advances in treatment have been made. Despite advances in the management of PVD, the mortality rate remains disproportionate.
Include: 31 videos + 1 pdf, size: 11.7 GB
Samples for Courses Can be found here : Free Samples Here!
North American Thrombosis Forum Right Heart Symposium 2023 (Videos + PDF)
Comprehensive Update on Pulmonary Vascular Disease, Pulmonary Hypertension, and Right Ventricular Failure
The North American Thrombosis Forum (NATF) Right Heart Symposium 2023 provides an in-depth exploration of pulmonary vascular disease (PVD), pulmonary hypertension (PH), right ventricular (RV) dysfunction, and right heart failure. This advanced educational program brings together leading experts in cardiology, pulmonology, critical care, imaging, and vascular medicine to discuss the latest diagnostic techniques, hemodynamic assessment tools, pharmacologic therapies, and emerging interventions for right heart disease.
Designed for clinicians and researchers managing patients with pulmonary hypertension and right ventricular disorders, the symposium emphasizes early recognition, accurate diagnosis, and evidence-based treatment strategies to improve patient outcomes.
Format: 31 Videos + 1 PDF
File Size: 11.7 GB
Year: 2023
Specialty: Pulmonary Hypertension | Right Heart Failure | Cardiology | Pulmonary Vascular Disease
Course Overview
Pulmonary vascular disease encompasses a diverse group of conditions that progressively increase pulmonary vascular resistance and place significant stress on the right ventricle. If untreated, these disorders often lead to right ventricular failure, impaired quality of life, and increased mortality.
Despite substantial therapeutic advances, pulmonary hypertension remains underdiagnosed and frequently recognized only after significant disease progression. The NATF Right Heart Symposium 2023 focuses on improving clinician understanding of right heart physiology, pulmonary vascular remodeling, advanced imaging, hemodynamics, and emerging therapies that may alter disease progression.
Participants gain practical insights into both acute and chronic forms of pulmonary hypertension and learn how to optimize care across a broad spectrum of pulmonary vascular disorders.
Target Audience
This course is designed for:
Physicians
• Cardiologists
• Pulmonary Hypertension Specialists
• Pulmonologists
• Critical Care Physicians
• Heart Failure Specialists
• Interventional Cardiologists
• Congenital Heart Disease Specialists
• Internal Medicine Physicians
Researchers
• Cardiovascular Researchers
• Pulmonary Vascular Disease Investigators
Advanced Practice Providers
• Nurse Practitioners
• Physician Assistants
Allied Health Professionals
• Pulmonary Hypertension Program Coordinators
• Cardiovascular Nurses
• Respiratory Therapists
Learning Objectives
Upon completion of this course, participants should be able to:
• Review advanced imaging techniques for right ventricular assessment
• Evaluate pulmonary vascular remodeling using modern diagnostic tools
• Apply pharmacologic therapies for right ventricular dysfunction
• Understand contemporary treatment approaches for pulmonary hypertension
• Assess novel interventional and device-based therapies
• Interpret advanced hemodynamic measurements
• Understand right ventricular–pulmonary arterial coupling
• Incorporate emerging disease-modifying therapies into clinical practice
Pulmonary Vascular Disease (PVD)
Understanding Pulmonary Vascular Disorders
Topics Covered
• Pulmonary Arterial Hypertension (PAH)
• Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
• Pulmonary Hypertension Due to Left Heart Disease
• COPD-Associated Pulmonary Hypertension
• Interstitial Lung Disease-Associated Pulmonary Hypertension
Disease Progression
Areas Covered
• Pulmonary Vascular Remodeling
• Increased Pulmonary Vascular Resistance
• Right Ventricular Adaptation
• Right Heart Failure Development
Pulmonary Hypertension
Modern Classification and Diagnosis
Topics Include
• WHO Classification of Pulmonary Hypertension
• Risk Stratification
• Screening Strategies
• Diagnostic Algorithms
• Early Disease Recognition
Advanced Diagnostic Evaluation
Areas Covered
• Echocardiography
• Right Heart Catheterization
• Biomarker Assessment
• Functional Testing
• Cardiopulmonary Exercise Testing
Right Ventricular Function and Failure
Right Ventricular Physiology
Topics Covered
• RV Structure and Function
• Ventricular Adaptation to Pressure Overload
• RV Remodeling
• RV Failure Mechanisms
Right Heart Failure Management
Areas Covered
• Acute RV Failure
• Chronic RV Dysfunction
• Hemodynamic Optimization
• Supportive Care Strategies
Advanced Imaging Techniques
Modern Right Heart Imaging
Topics Include
• Echocardiographic Assessment
• Cardiac MRI
• CT Imaging
• Strain Imaging
• Quantitative RV Evaluation
Pulmonary Vascular Remodeling Assessment
Areas Covered
• Structural Changes
• Functional Assessment
• Monitoring Disease Progression
• Therapeutic Response Evaluation
Pharmacologic Therapies
Pulmonary Hypertension Medications
Topics Covered
• Endothelin Receptor Antagonists
• Phosphodiesterase-5 Inhibitors
• Prostacyclin Therapies
• Soluble Guanylate Cyclase Stimulators
Emerging Therapies
Areas Covered
• PDGF Signaling Modulation
• TGF-Beta Pathway Therapies
• Disease-Modifying Strategies
• Novel Investigational Agents
Interventional and Device-Based Therapies
Advanced Treatment Options
Topics Include
• Balloon Pulmonary Angioplasty
• Mechanical Support Strategies
• Catheter-Based Therapies
• Device Innovations
CTEPH Interventions
Areas Covered
• Pulmonary Endarterectomy
• Interventional Procedures
• Multidisciplinary Care Approaches
Advanced Hemodynamics
Right Heart Catheterization
Topics Covered
• Hemodynamic Measurements
• Pressure Waveform Interpretation
• Pulmonary Vascular Resistance
• Cardiac Output Assessment
RV–Pulmonary Artery Coupling
Areas Covered
• Physiologic Principles
• Clinical Relevance
• Prognostic Value
• Therapeutic Implications
Pulmonary Embolism and Acute RV Dysfunction
Acute Pulmonary Vascular Disease
Topics Include
• Massive Pulmonary Embolism
• Acute RV Failure
• Emergency Management
• Hemodynamic Stabilization
Congenital Heart Disease and Pulmonary Hypertension
Special Populations
Topics Covered
• Congenital Heart Disease-Associated PH
• Eisenmenger Syndrome
• Long-Term Management
• Transition of Care
Case-Based Learning
Participants review:
• Pulmonary Arterial Hypertension Cases
• CTEPH Management Strategies
• Acute RV Failure Scenarios
• Complex Pulmonary Hypertension Evaluations
• Advanced Hemodynamic Cases
• Interventional Therapy Decision-Making
• Imaging Interpretation Challenges
Educational Highlights
Expert Faculty
Internationally recognized specialists in pulmonary vascular disease, heart failure, critical care, and cardiovascular imaging.
Comprehensive Right Heart Focus
Dedicated emphasis on right ventricular function and pulmonary circulation.
Cutting-Edge Therapies
Reviews emerging disease-modifying treatments and novel therapeutic targets.
Practical Clinical Application
Case-based discussions provide immediate relevance to clinical practice.
Why This Course Stands Out
✔ Comprehensive Pulmonary Hypertension Review
✔ Advanced Right Ventricular Physiology Education
✔ Pulmonary Vascular Disease Management
✔ Advanced Hemodynamic Interpretation
✔ Right Heart Catheterization Review
✔ Cardiac MRI and Advanced Imaging Training
✔ Emerging Disease-Modifying Therapies
✔ CTEPH Diagnosis and Treatment
✔ RV–Pulmonary Artery Coupling Concepts
✔ Pulmonary Embolism and Acute RV Failure Management
✔ Expert Multidisciplinary Faculty
✔ Case-Based Learning Approach
Who Should Take This Course?
Ideal for:
• Cardiologists
• Pulmonary Hypertension Specialists
• Pulmonologists
• Heart Failure Specialists
• Critical Care Physicians
• Congenital Heart Disease Specialists
• Cardiology Fellows
• Pulmonary Fellows
• Advanced Practice Providers
Clinical & Educational Value
The North American Thrombosis Forum Right Heart Symposium 2023 delivers a comprehensive and contemporary review of pulmonary vascular disease, pulmonary hypertension, right ventricular dysfunction, and emerging therapies. Through expert instruction and practical case discussions, participants gain advanced knowledge essential for improving outcomes in patients with complex right heart and pulmonary vascular disorders.
Topics:
- Agenda.pdf
Assessing RV Function and Response to Treatment Advanced Imaging Approaches to Assessing Pulmonary Vascular Remodeling and RV Function.mp4
Assessing RV Function and Response to Treatment Assessing the RV- It’s All in the Curves.mp4
Assessing RV Function and Response to Treatment Assessing the RV- It’s the Dots, Not the Curves- Focus on Speckle Tracking and Strain Imaging.mp4
Assessing RV Function and Response to Treatment Is There a Role for PET or Molecular Imaging to Assess the RV.mp4
Assessing RV Function and Response to Treatment Panel Discussion.mp4
KEYNOTE PRESENTATION Assessing Right Ventricular Function Using Exercise, Imaging, and Hemodynamics.mp4
Novel Interventional and Pharmaceutical Approaches In the Age of Disease Modifiers, What Should our Approach to Treatment be.mp4
Novel Interventional and Pharmaceutical Approaches Intrapulmonary Artery Balloon Pump – Why and When.mp4
Novel Interventional and Pharmaceutical Approaches Panel discussion.mp4
Novel Interventional and Pharmaceutical Approaches Targeting BMPR2.mp4
Novel Interventional and Pharmaceutical Approaches Targeting Metabolism – is it a Viable Target.mp4
Pulmonary Embolism Clot In Transit – What is the Optimal Approach.mp4
Pulmonary Embolism Optimal Duration of Anticoagulation – 2 months; 3 months; life long.mp4
Pulmonary Embolism Panel discussion.mp4
Pulmonary Embolism Provoked and Unprovoked – What is the Difference, and does it Matter.mp4
Pulmonary Embolism What does Clot Burden Mean.mp4
Pulmonary Non-Hypertensive Vascular Pathology Anomalous Venous Return – Diagnosis and Management.mp4
Pulmonary Non-Hypertensive Vascular Pathology Left to Right Shunting and Enhanced Pulmonary Blood Flow – Why is the Patient Dyspneic.mp4
Pulmonary Non-Hypertensive Vascular Pathology Panel discussion.mp4
Pulmonary Non-Hypertensive Vascular Pathology Pulmonary Artery Aneurysm – is it a Surgical Disease.mp4
Pulmonary Non-Hypertensive Vascular Pathology Pulmonary AVM’s without HHT.mp4
The Art of Hemodynamics – What does the RHC Really Tell Us Clinical Implications of Aggressive Afterload Reduction.mp4
The Art of Hemodynamics – What does the RHC Really Tell Us Panel discussion.mp4
The Art of Hemodynamics – What does the RHC Really Tell Us Pulmonary Artery Hemodynamics- the Action is in the Proximal Vasculature.mp4
The Art of Hemodynamics – What does the RHC Really Tell Us Pulmonary Artery Hemodynamics- the Action is in the Small Vessels.mp4
The Art of Hemodynamics – What does the RHC Really Tell Us RV-PA Coupling, Afterload, and Pressure-Volume Curves.mp4
The Failing Right Heart – What Are the Realistic Salvage Options Inotropic Support in RV Failure – Is There Really a Role.mp4
The Failing Right Heart – What Are the Realistic Salvage Options Panel discussion.mp4
The Failing Right Heart – What Are the Realistic Salvage Options Vasopressor Support in RH Failure – Can We Optimize RV Mechanics and Coronary Perfusion.mp4
The Failing Right Heart – What Are the Realistic Salvage Options When and why is the RV too Sick for Lung Transplantation.mp4
The Failing Right Heart – What Are the Realistic Salvage Options When to Consider MCS – Hemodynamic, Physiologic, and Patient Selection.mp4
Related products
Anesthesiology & pain medicine
Critical Care - Emergency medicine
Internal Medicine
Medical Accounts
Critical Care - Emergency medicine
Anesthesiology & pain medicine
Internal Medicine
Critical Care - Emergency medicine
2022 UPDATES IN THERAPEUTICS: CRITICAL CARE PHARMACY PREPARATORY REVIEW AND RECERTIFICATION COURSE